Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism

Thromb Res. 2016 Dec:148:145-151. doi: 10.1016/j.thromres.2016.09.007. Epub 2016 Sep 13.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Factor Xa Inhibitors / adverse effects
  • Factor Xa Inhibitors / therapeutic use*
  • Female
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Rivaroxaban / adverse effects
  • Rivaroxaban / therapeutic use*
  • Venous Thromboembolism / drug therapy*
  • Young Adult

Substances

  • Factor Xa Inhibitors
  • Rivaroxaban